Lv01
0 积分 2026-06-30 加入
Advances in Antibody–Drug Conjugates for Endometrial Cancer
1小时前
已完结
First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Solid Tumors
2小时前
已完结
Progress in RAS‐targeted therapeutic strategies: From small molecule inhibitors to proteolysis targeting chimeras
4个月前
已完结
皖公网安备34019202002308
